Pharma BD Deal Intelligence

Merck KGaA / Rapid Micro Biosystems, Inc.

2025 · Co-Development · Complete

On February 27, 2025 Rapid Micro Biosystems announced a global distribution and collaboration agreement with the Life Science business of Merck KGaA, Darmstadt, Germany. The agreement significantly extends the commercial reach of Rapid Micro's Growth Direct automated microbial quality-control platform through Merck's expanded global sales channels and creates opportunities for collaboration on supply chain efficiencies, services and joint product development. Financial terms were not disclosed.

This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2030 at the earliest for this deal, once/if it closes.

Key facts

Announced Feb 27, 2025
Deal type Co-Development

← Browse all deals · How we score deals

More: 2025 deals · Merck KGaA deals

Merck KGaA / Rapid Micro Biosystems, Inc.

Key facts

Related deals